Literature DB >> 30498309

Extracellular hydrolytic enzyme activities of the different Candida spp. isolated from the blood of the Intensive Care Unit-admitted patients.

Nidhi Pandey1, Munesh Kumar Gupta1, Ragini Tilak1.   

Abstract

BACKGROUND: Candida spp. secretes various extracellular hydrolytic enzymes. These enzymes are the important virulence factor for the pathogenesis of Candida. We assessed four different enzymatic activities of Candida isolates obtained from bloodstream infections.
MATERIALS AND METHODS: We isolated 79 strains of different Candida species from the blood of the Intensive Care Unit-admitted patients. Species were identified by conventional methods including culture characteristic, germ tube, sugar assimilation, and Dalmau's culture technique. Phospholipase, proteinase, hemolysin, and esterase enzymatic activities were determined by the Plate method.
RESULTS: Non albicans candida were the most common isolates from the blood of the ICU admitted patient with a predominance of Candida tropicalis. Hemolytic activity was the most prominent enzyme activity followed by the proteinase activity. Candida albicans (89.86%) was the major proteinase producer, while 95.8% of C. tropicalis produced hemolysin. No esterase activity was shown by the Candida glabrata and Candida krusei.
CONCLUSION: No significant difference was observed between the two most common causative agents of candidemia: C. albicans and C. tropicalis.

Entities:  

Keywords:  Candidemia; esterase; hemolysin; phospholipase; proteinase; virulence factor

Year:  2018        PMID: 30498309      PMCID: PMC6210849          DOI: 10.4103/JLP.JLP_81_18

Source DB:  PubMed          Journal:  J Lab Physicians        ISSN: 0974-2727


Introduction

Candida infections are the leading cause of the morbidity and mortality in the hospitalized patients.[12] Candida infections may disseminate hematogenously to the various organs. These disseminated Candida infections usually occur in patients with a history of prolonged antibiotic exposure, immunosuppressive treatment, and patients on parenteral nutrition.[13] Different species of Candida are attributed as a cause of these disseminated infections, but four species, namely Candida albicans, Candida tropicalis, Candida parapsilosis, and Candida krusei, account for as much as 95% of these infections.[1] Previously, C. albicans was the most common cause of bloodstream fungal infections, but nowadays, non-albicans Candida has superseded the former.[45] Candida spp. has grown from successful commensalism to pathogens in various body sites. Candida spp. secrete different extracellular enzymes as phospholipase, protease, and esterase. These hydrolytic enzymes contribute the microbial pathogenicity by accentuating its adhesion, tissue damage, immune system evasion, as well as its dissemination. Hemolysin is another virulence factor that degrades the red blood cells, and iron is released which is taken up by the yeast cells.[67] In this study, we have determined the extracellular enzyme activity of the Candida species, isolated from the blood of the Intensive Care Unit (ICU)-admitted patients.

Materials and Methods

Candida spp. was isolated from the blood of the ICU-admitted patients at a tertiary care center at Sir Sunderlal Hospital, Banaras Hindu University, Varanasi. Candida was identified based on microscopic examination, culture characteristics, germ tube formation, sugar fermentation, sugar assimilation, morphology on cornmeal agar, and color on CHROMagar. The isolated Candida spp. was screened for the extracellular enzymatic activities, that is, phospholipase, proteinase, hemolysin, and esterase. Phospholipase activity was determined by the method described earlier by Price et al.,[8] with little modification done by Costa et al.[9] In this, Sabouraud's dextrose agar (SDA) medium was supplemented with 1 mol/L sodium chloride, 0.005 mol/L calcium chloride, and 8% sterile egg yolk suspension. Proteinase activity was determined using the bovine serum albumin agar.[10] Tween 80 opacity medium was used to determine the esterase activity.[10] For hemolysin activity, SDA plates supplemented with 3% glucose and 7% sheep blood were used.[11] Ten microliters of a thick suspension of each strain were placed in the center of the plates which were incubated at 37°C for 5 days. The test was performed in triplicates. Average value of the colony diameter (a) and the diameter of the colony plus the precipitation zone (b) were measured. The enzyme activity was expressed as Pz value (a/b) as described by Price et al. All enzymatic activity index was classified as follows: Pz = 1, negative activity; 0.64 < Pz <0.99, positive; and Pz ≤0.64, strongly positive.[6]

Results

A total of 79 strains of Candida spp. were isolated from the blood of the patients, admitted in the ICU. Most of the patients were male with an M:F of 1.82:1. Majority of the Candida spp were isolated from the blood of neonates (n = 41), followed by patients below 18 years of age group (n = 16) [Table 1]. Out of these 79 isolates, in comparison to C. albicans, non-albicans candida (n = 63) were predominant. These non-albicans (n = 63) were categorized as follows: C. tropicalis (n = 24), C. krusei (n = 11), C. parapsilosis (n = 9), Candida glabrata (n = 5), and unidentified (n = 14) [Table 2].
Table 1

Demographic characteristics of patients with bloodstream infection

Table 2

Extracellular enzyme production by Candida spp.

Demographic characteristics of patients with bloodstream infection Extracellular enzyme production by Candida spp. Extracellular enzyme activities of these isolated Candida spp. were determined by the Plate method. Proteinase, phospholipase, and hemolysin enzymes were produced by most of the Candida species although strains of C. krusei and C. glabrata failed to produce the esterase enzyme [Figure 1]. Hemolysin activity was shown by 89.86% of the isolated Candida spp., whereas other extracellular enzymes such as proteinase, phospholipase, and esterase were produced only by 84.72%, 55.69%, and 37.97% of the strains, respectively [Table 3 and Figure 2]. Strong proteinase activity was shown by the C. albicans (93.75%), followed by the C. tropicalis (87.5%). Strong hemolytic activity was shown by 95.85% of the C. tropicalis, followed by the C. albicans (81.25%). About 56.25% of C. albicans strains followed by 54.16% C. tropicalis were strong esterase producers. Only one C. parapsilosis isolate was able to strong esterase producer. No statistical analysis could be performed for esterase activity, as the number of isolates producing esterase enzyme was considerably small. No significant difference between the enzyme production by the C. albicans and non-albicans Candida was observed. Similarly, no significant difference was observed between the two most common causes of candidemia, C. albicans, and C. tropicalis [Table 3].
Figure 1

Percentage of Candida strain with extracellular enzyme production

Table 3

Distribution of Candida spp. showing different virulence attributes

Figure 2

Percentage of extracellular enzymes produced by isolated Candida spp on the basis of score value

Percentage of Candida strain with extracellular enzyme production Distribution of Candida spp. showing different virulence attributes Percentage of extracellular enzymes produced by isolated Candida spp on the basis of score value

Discussion

Bloodstream Candida infections in ICU-admitted patients are the life-threatening affliction with an incidence of 0.24–34.3 patients/1000 ICU admissions.[12] These disseminated Candida infections may be dependent on various host defense mechanisms and fungal virulence attributes. These Candida infections are common in the ICU patients, taking parenteral nutrition, prolonged antibiotics, and immunocompromised conditions. Previously, C. albicans was considered as the most common cause of bloodstream infection, but in the present study, C. tropicalis outnumber the cases. Similar results of C. tropicalis as the most common etiology of Candida infection in ICU patients have been reported by Costa et al. and Chakrabarti et al.[412] In comparison to studies performed in European and South American countries, C. parapsilosis is considered as the most common cause of Candida bloodstream infection. This variation may be attributed to the environmental factors, use of central lines, life-supporting devices, and antibiotics usages. In our study, C. tropicalis was the most common isolated Candida followed by the C. albicans (n = 16), C. krusei (n = 11), and C. parapsilosis (n = 9). High C. krusei strains (n = 9) isolation may be due to the frequent use of fluconazole either as prophylactic or therapeutic.[13] Candida secretes various extracellular hydrolytic enzymes which act as important virulence factors.[62] These hydrolytic enzymes degrade the cellular component of tissues and facilitate their survival, adhesion, invasion, and dissemination. Phospholipase, proteinase, lipase, esterase, hemolysin, etc., are the common hydrolytic enzymes. Phospholipase and proteinase hydrolytic enzymes are considered as the two most common virulence factors as they contribute to the Candida-host interaction. Proteinase enzyme degrades the surface protein and disrupts the local immunity, resulting in tissue invasion. Phospholipase enzyme degrades the phospholipid component of the cell membrane, resulting in cell damage and lysis which accentuates its dissemination. In our study, higher phospholipase and proteinase enzyme production was shown by the C. albicans strains. Similar results of higher enzyme production have been reported by Canela et al. and Mutlu Sariguzel et al.[614] In our study, in comparison to the C. tropicalis, phospholipase and proteinase were produced by a higher number of the C. albicans strain, whereas hemolysin and esterase enzymes were produced by a higher number of the C. tropicalis strains. Hemolysin is the enzyme which degrades the cellular component of the blood. This virulence property of Candida spp. helps to acquire iron by degrading hemoglobin from the host and further help pathogen to persist and survive.[61516] Hemolysin activity was shown by 95.8% of C. tropicalis and 90.9% strains of the C. krusei strains. Only 87.5% strain of C. albicans produced hemolysin activity. Hemolysin and proteinase enzymes were produced by >80% of the isolated Candida spp. Similar results of higher hemolysin production have been reported by Riceto et al.[17] Esterase enzyme is also an important virulence factor which degrades the ester bonds and accentuates its tissue invasion. About 56% of C. albicans showed the esterase activity in comparison to the C. tropicalis where only 54% strain showed the esterase activity. This result is concordant with a study conducted by Kumar et al., where the author reported C. albicans and C. tropicalis species with the highest rate of esterase activity.[18] No activity was observed in the isolated strains of the C. glabrata and C. krusei, which are considered as the intrinsic fluconazole resistant. These results are contradictory to the study published by the Fatahinia et al., where they reported the 3+ level esterase activities in C. glabrata isolated from diabetic patients suffering from oral candidiasis.[10] On the other hand, they have also reported C. glabrata as the lowest esterase producer in vulvovaginal candidiasis patients.[19] Although esterase activity was low, yet its mechanism in virulence due to cytotoxic effects in host tissue has been reported by Williams and Lewis[20] In our study, these enzymes were produced by the both common C. albicans and C. tropicalis (P > 0.05) that necessitate the need for search of other factors responsible for their virulence. Our study has a limitation as a considerable number of isolates remain unidentified which needs to be done for proper assessment.

Conclusion

Non-albicans candida with a preponderance of C. tropicalis is the most common isolated yeast from the blood of the ICU-admitted patients. No statistically significant difference for enzymatic activity was observed among the C. albicans and C. tropicalis. Intrinsic fluconazole-resistant C. krusei and C. glabrata failed to produce any esterase activity which needs to be evaluated further.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  20 in total

1.  Esterase activity of Candida species isolated from immunocompromised hosts.

Authors:  Chethrapilly Purushothaman Girish Kumar; Thangam Menon; Thangavel Sundararajan; Sarathy Nalini; Mandayam Anandampillai Thirunarayan; Sikhamani Rajasekaran; Manjetti Venkatadesikalu
Journal:  Rev Iberoam Micol       Date:  2006-06       Impact factor: 1.044

2.  Determination of germ tube, phospholipase, and proteinase production by bloodstream isolates of Candida albicans.

Authors:  Antonella Souza Mattei; Sydney Hartz Alves; Cecília Bittencourt Severo; Luciana da Silva Guazzelli; Flávio de Mattos Oliveira; Luiz Carlos Severo
Journal:  Rev Soc Bras Med Trop       Date:  2013 May-Jun       Impact factor: 1.581

3.  Incidence, characteristics and outcome of ICU-acquired candidemia in India.

Authors:  Arunaloke Chakrabarti; Prashant Sood; Shivaprakash M Rudramurthy; Sharon Chen; Harsimran Kaur; Malini Capoor; Deepinder Chhina; Ratna Rao; Vandana Kalwaje Eshwara; Immaculata Xess; Anupama J Kindo; P Umabala; Jayanthi Savio; Atul Patel; Ujjwayini Ray; Sangeetha Mohan; Ranganathan Iyer; Jagdish Chander; Anita Arora; Raman Sardana; Indranil Roy; B Appalaraju; Ajanta Sharma; Anjali Shetty; Neelam Khanna; Rungmei Marak; Sanjay Biswas; Shukla Das; B N Harish; Sangeeta Joshi; Deepak Mendiratta
Journal:  Intensive Care Med       Date:  2014-12-16       Impact factor: 17.440

Review 4.  A review of Candida species causing blood stream infection.

Authors:  S Giri; A J Kindo
Journal:  Indian J Med Microbiol       Date:  2012 Jul-Sep       Impact factor: 0.985

5.  Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: a 4-year survey.

Authors:  Viviane Gevezier da Costa; Regina Mariuza Borsato Quesada; Aline Tancler Stipp Abe; Luciana Furlaneto-Maia; Márcia Cristina Furlaneto
Journal:  Mycopathologia       Date:  2014-08-08       Impact factor: 2.574

6.  Plate method for detection of phospholipase activity in Candida albicans.

Authors:  M F Price; I D Wilkinson; L O Gentry
Journal:  Sabouraudia       Date:  1982-03

7.  Enzymatic and hemolytic activity in different Candida species.

Authors:  Érika Bezerra de Melo Riceto; Ralciane de Paula Menezes; Mário Paulo Amante Penatti; Reginaldo Dos Santos Pedroso
Journal:  Rev Iberoam Micol       Date:  2014-04-01       Impact factor: 1.044

8.  Pathogenesis and treatment of oral candidosis.

Authors:  David Williams; Michael Lewis
Journal:  J Oral Microbiol       Date:  2011-01-28       Impact factor: 5.474

9.  Antifungal susceptibility patterns, in vitro production of virulence factors, and evaluation of diagnostic modalities for the speciation of pathogenic Candida from blood stream infections and vulvovaginal candidiasis.

Authors:  Chaitanya Tellapragada; Vandana Kalwaje Eshwara; Ruqaiyah Johar; Tushar Shaw; Nidhi Malik; Parvati V Bhat; Asha Kamath; Chiranjay Mukhopadhyay
Journal:  J Pathog       Date:  2014-07-07

10.  Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.

Authors:  Hatice Turk Dagi; Duygu Findik; Cigdem Senkeles; Ugur Arslan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-05-31       Impact factor: 3.944

View more
  4 in total

Review 1.  Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen.

Authors:  Manuela Gómez-Gaviria; Héctor M Mora-Montes
Journal:  Infect Drug Resist       Date:  2020-06-10       Impact factor: 4.003

2.  In vitro activities of Traganum nudatum and Mentha pulegium extracts combined with amphotericin B against Candida albicans in production of hydrolytic enzymes.

Authors:  Ikram Tefiani; Sidi Mohammed Lahbib Seddiki; Moustafa Yassine Mahdad
Journal:  Curr Med Mycol       Date:  2020-09

3.  A comparative study on production of extracellular hydrolytic enzymes of Candida species isolated from patients with surgical site infection and from healthy individuals and their co-relation with antifungal drug resistance.

Authors:  Rakhshanda Erum; Farkhunda Samad; Adnan Khan; Shahana Urooj Kazmi
Journal:  BMC Microbiol       Date:  2020-12-03       Impact factor: 3.605

4.  Catechol thwarts virulent dimorphism in Candida albicans and potentiates the antifungal efficacy of azoles and polyenes.

Authors:  Ravi Jothi; Ravichellam Sangavi; Ponnuchamy Kumar; Shunmugiah Karutha Pandian; Shanmugaraj Gowrishankar
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.